Skip to main content

Table 1 Table 1

From: Molecular-based allergy diagnostics in the real world: evidence for a cost explosion and an impact vacuum

  Adults (n=70) Children (n=53)
Mean age (sd) 31.9 (12.3) 9.2 (4.2)
% cost increase with MA (range) 156 (11-900) 197 (9-600)
MA test results altered management, n(%) 6 (8.6) 7 (13.2)
MA test results provided useful diagnostic support, n(%) 9 (12.8) 2 (3.7)
MA test results had no impact on diagnosis or management, n(%) 55 (78.6) 44 (83)